Journal of International Oncology››2022,Vol. 49››Issue (10): 586-591.doi:10.3760/cma.j.cn371439-20220726-00116
• Original Articles •Previous ArticlesNext Articles
Duan Shuai, Guo Chenming, Li Huifang, Dilimulati · Aisimutula()
Received:
2022-07-26Revised:
2022-09-12Online:
2022-10-08Published:
2022-12-01Contact:
Dilimulati · Aisimutula E-mail:mlt0306@sina.comDuan Shuai, Guo Chenming, Li Huifang, Dilimulati · Aisimutula. Trends in incidence and mortality of female breast cancer in China from 1990 to 2019 and age-period-cohort model analysis[J]. Journal of International Oncology, 2022, 49(10): 586-591.
[1] | Sung H, Ferlay J, Siegel RL, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J]. CA Cancer J Clin, 2021, 71(3): 209-249. DOI: 10.3322/caac.21660. doi:10.3322/caac.21660 |
[2] | Cao W, Chen HD, Yu YW, et al. Changing profiles of cancer burden worldwide and in China: a secondary analysis of the global cancer statistics 2020[J]. Chin Med J (Engl), 2021, 134(7): 783-791. DOI: 10.1097/CM9.0000000000001474. doi:10.1097/CM9.0000000000001474 |
[3] | GBD 2019 Risk Factors Collaborators. Global burden of 87 risk factors in 204 countries and territories, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019[J]. Lancet, 2020, 396(10258): 1223-1249. DOI: 10.1016/S0140-6736(20)30752-2. doi:10.1016/S0140-6736(20)30752-2pmid:33069327 |
[4] | GBD 2017 Disease and Injury Incidence and Prevalence Collaborators. Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017[J]. Lancet, 2018, 392(10159): 1789-1858. DOI: 10.1016/S0140-6736(18)32279-7. doi:S0140-6736(18)32279-7pmid:30496104 |
[5] | Armstrong RA. When to use the Bonferroni correction[J]. Ophthalmic Physiol Opt, 2014, 34(5): 502-508. DOI: 10.1111/opo.12131. doi:10.1111/opo.12131 |
[6] | Rosenberg PS, Check DP, Anderson WF. A web tool for age-period-cohort analysis of cancer incidence and mortality rates[J]. Cancer Epidemiol Biomarkers Prev, 2014, 23(11): 2296-2302. DOI: 10.1158/1055-9965.EPI-14-0300. doi:10.1158/1055-9965.EPI-14-0300 |
[7] | 杨秀丽. DNA损伤修复基因XPG、XPC、WRN单核苷酸多态性与乳腺癌易感性的研究[D]. 沈阳: 中国医科大学, 2010. DOI: 10.7666/d.y2052036. doi:10.7666/d.y2052036 |
[8] | 郑文龙, 张辉, 张爽, 等. 天津市1999-2017年女性乳腺癌死亡水平变化趋势分析[J]. 中华流行病学杂志, 2020, 41(9): 1477-1481. DOI: 10.3760/cma.j.cn112338-20191018-00741. doi:10.3760/cma.j.cn112338-20191018-00741 |
[9] | Tu WJ, Zeng XW, Liu Q. Aging tsunami coming: the main finding from China's seventh national population census[J]. Aging Clin Exp Res, 2022, 34(5): 1159-1163. DOI: 10.1007/s40520-021-02017-4. doi:10.1007/s40520-021-02017-4 |
[10] | Sun L, Sadique Z, Dos-Santos-Silva I, et al. Cost-effectiveness of breast cancer screening programme for women in rural China[J]. Int J Cancer, 2019, 144(10): 2596-2604. DOI: 10.1002/ijc.31956. doi:10.1002/ijc.31956pmid:30367451 |
[11] | Zou XN. Epidemic trend, screening, and early detection and treatment of cancer in Chinese population[J]. Cancer Biol Med, 2017, 14(1): 50-59. DOI: 10.20892/j.issn.2095-3941.2016.0047. doi:10.20892/j.issn.2095-3941.2016.0047 |
[12] | 王永斌, 马石头, 王焕, 等. 我国妇女生育水平变化及未来人口预测[J]. 中国卫生统计, 2017, 34(1): 34-36, 39. |
[13] | 周淼, 周晓明, 周业庭. 乳腺癌与人乳头瘤病毒感染关系研究进展[J]. 中华实验外科杂志, 2009, 26(6): 813-814. DOI: 10.3760/cma.j.issn.1001-9030.2009.06.059. doi:10.3760/cma.j.issn.1001-9030.2009.06.059 |
[14] | Kobayashi S, Sugiura H, Ando Y, et al. Reproductive history and breast cancer risk[J]. Breast Cancer, 2012, 19(4): 302-308. DOI: 10.1007/s12282-012-0384-8. doi:10.1007/s12282-012-0384-8pmid:22711317 |
[15] | Heer E, Harper A, Escandor N, et al. Global burden and trends in premenopausal and postmenopausal breast cancer: a population-based study[J]. Lancet Glob Health, 2020, 8(8): e1027-e1037. DOI: 10.1016/S2214-109X(20)30215-1. doi:10.1016/S2214-109X(20)30215-1pmid:32710860 |
[16] | 仇雨临, 王昭茜, 冉晓醒. 中国共产党领导下的中国医保: 发展道路与经验总结[J]. 东岳论丛, 2021, 42(10): 5-11. DOI: 10.15981/j.cnki.dongyueluncong.2021.10.002. doi:10.15981/j.cnki.dongyueluncong.2021.10.002 |
[1] | Wang Ying, Liu Nan, Guo Bing.Advances of antibody-drug conjugate in the therapy of metastatic breast cancer[J]. Journal of International Oncology, 2024, 51(6): 364-369. |
[2] | Sa Qiang, Xu Hangcheng, Wang Jiayu.Advances in immunotherapy for breast cancer[J]. Journal of International Oncology, 2024, 51(4): 227-234. |
[3] | Yang Zhi, Lu Yiqiao, Gu Huayan, Ding Jialing, Guo Guilong.Research progress of tumor microenvironment mediated drug resistance in targeted therapy of breast cancer[J]. Journal of International Oncology, 2024, 51(4): 235-238. |
[4] | Chen Boguang, Wang Sugui, Zhang Yongjie.Role of serum cholinesterase and inflammatory markers in the prognosis of stage ⅠA -ⅢA breast cancer[J]. Journal of International Oncology, 2024, 51(2): 73-82. |
[5] | He Jiahui, Hu Qinyong.Comparative analysis of lung cancer incidence and mortality trends and risk factors in China and the United States based on GBD data[J]. Journal of International Oncology, 2024, 51(1): 29-36. |
[6] | Gu Huayan, Zhu Teng, Guo Guilong.Breast microbiota and breast cancer: present and future[J]. Journal of International Oncology, 2024, 51(1): 55-58. |
[7] | Wang Jing, Xu Wenting.Value of NLR, CEA combined with coagulation indicators in the differential diagnosis of benign and malignant breast nodules with a diameter ≤ 1.0 cm[J]. Journal of International Oncology, 2023, 50(9): 520-526. |
[8] | Feng Chengtian, Huang Furong, Cao Shiyu, Wang Jianyu, Nanding Abiyasi, Jiang Yongdong, Zhu Juanying.Relationships between HER2 protein expression and imaging features in HER2 positive breast cancer patients[J]. Journal of International Oncology, 2023, 50(9): 527-531. |
[9] | Feng Dongxu, Wu Wei, Gao Pingfa, Wang Jun, Shi Lijuan, Chen Dawei, Li Wenbing, Zhang Meifeng.Effects of miR-451 on glycolysis and apoptosis of breast cancer cells by regulating Rho/ROCK1 pathway[J]. Journal of International Oncology, 2023, 50(8): 449-456. |
[10] | Pan Shulan, Liu Chang, He Ping.Effect of fritinib on angiogenesis, tumor growth and IRE1-ASK1-JNK pathway in triple negative breast cancer[J]. Journal of International Oncology, 2023, 50(8): 457-462. |
[11] | Zhao Qianwen, Peng Danli, Qin Tao, Mao Guofei, Tang Hui, Yang Jun.Analysis of global cancer incidence and mortality from 1990 to 2019[J]. Journal of International Oncology, 2023, 50(7): 425-431. |
[12] | Wang Wende, Zeng De.Research progress on the mechanism of endocrine therapy resistance for breast cancer[J]. Journal of International Oncology, 2023, 50(6): 352-356. |
[13] | Li Qingshan, Xie Xin, Zhang Nan, Liu Shuai.Research progress on the application of combining radiotherapy and systemic therapy in breast cancer[J]. Journal of International Oncology, 2023, 50(6): 362-367. |
[14] | Zhu Jun, Huang Meijin, Li Yuan, Liu Zegang, Xun Xin, Chen Hong.Research progress on targeted therapy of breast cancer with low expression of HER2[J]. Journal of International Oncology, 2023, 50(4): 236-240. |
[15] | Zhou Ting, Xu Shaohua, Mei Lin.Efficacy and safety of bevacizumab combined with capecitabine in the treatment of advanced breast cancer[J]. Journal of International Oncology, 2023, 50(3): 144-149. |
Viewed | ||||||
Full text |
|
|||||
Abstract |
|
|||||